Medical - Healthcare Plans · NYSE
Current Price
$198.39
PE Ratio (TTM)
n/m
Intrinsic Value
Use the calculator below to estimate
COMPETITIVE MOAT
↑Government Contract Expertise
Molina excels at navigating complex government contracts for Medicare and Medicaid. This deep understanding and established relationships create high barriers to entry for competitors.
↑Focus on Underserved Populations
Specializing in low-income and vulnerable populations builds strong community ties and brand loyalty. This niche focus fosters deep member engagement and retention.
↑Integrated Care Model
Molina's approach to integrating care services allows for better cost management and member outcomes. This operational efficiency can lead to a competitive cost advantage.
INVESTMENT RISKS
↓Rising Medical Costs
Increasing medical costs (MCR) can erode profitability if not offset by premium increases or cost controls. This directly impacts the company's bottom line.
↓Earnings Volatility
Molina's earnings can be volatile due to the nature of government contracts and potential for unexpected cost fluctuations. Analysts are forecasting earnings declines.
↓Competitive Performance Gaps
Competitors like Oscar Health are demonstrating stronger membership growth and earnings prospects. This suggests potential market share erosion.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Molina Healthcare, Inc. respond.
Open PE Calculator for MOHMolina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
PE Ratio (TTM)
n/m
PEG Ratio
3.13
Earnings Yield
-0.47%
ROE (TTM)
-1.2%
Revenue/Share (TTM)
$847.13
Debt/Equity
0.95x
The trailing twelve-month PE ratio of MOH reflects how much investors pay per dollar of Molina Healthcare, Inc.'s earnings. This metric is most useful when compared to Medical - Healthcare Plans peers and the company's own historical range.
MOH's PE of -325.2x combined with a PEG ratio of 3.13 provides a growth-adjusted perspective. A PEG above 2.0 means the P/E is high relative to the earnings growth rate. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Medical - Healthcare Plans, a DCF analysis may be more appropriate.
To value Molina Healthcare, Inc. using PE: (1) Compare the current PE (-325.2x) against the Medical - Healthcare Plans median to assess relative pricing, (2) check the PEG ratio (3.13) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
MOH's PEG ratio is 3.13, calculated by dividing the PE ratio (-325.2x) by the expected earnings growth rate. A PEG above 2.0 means the P/E is high relative to the expected earnings growth rate. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how MOH is priced versus Medical - Healthcare Plans peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value MOH with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-11-20. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.